Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study
Florent Joly, Frank Bridoux(Université de Poitiers), Bertrand Knebelmann(Hôpital Necker-Enfants Malades), Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges), Viviane Gnemmi(Université Paris-Saclay), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), Vincent Javaugue(Université de Poitiers), Sébastien Bender(Centre National de la Recherche Scientifique), M. Nouvier(Hôpital Lyon Sud), Dominique Nochy(Hôpital Européen Georges-Pompidou), Vincent Audard(Inserm), Christophe Sirac(Centre National de la Recherche Scientifique), Camille Cohen(Inserm), François Provôt(Centre Oscar Lambret), Jean Michel Goujon(Université de Poitiers), Mohamed Belmouaz(Centre de Référence des Maladies Autoinflammatoires et des Amyloses), Jean Paul Fermand(Université Paris Cité), Bertrand Arnulf(Université Paris Cité)
Cited by 124
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
|New England Journal of Medicine|2023|695